Metrics
- Price
- $14.06
- Market Cap $M
- 1,302
- Rel Volume
- 0.75
- Vol Up 2W
- 33.30%
- Vol Trend 2W
- -27.00%
- 1D
- -0.92%
- 1W
- -0.57%
- 1M
- +12.03%
- 1M Slope
- +14.88%
- 6M Range
- 114.16%
- Score
- 72.6
- Sharp
- 0.7
Volume
Profile
MeiraGTx is a clinical-stage genetic medicines company developing gene therapies for inherited retinal disease, salivary gland disorders, and other serious conditions.
Biotech
Healthcare
General